Results 101 to 110 of about 47,826 (189)

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A <i>DPYD</i> Variant Allele. [PDF]

JCO Precis Oncol
Heersche N, Knikman JE, Deenen MJ, Rosing H, van Schaik RHN, Beijnen JH, Schellens JHM, Gelderblom H, Guchelaar HJ, Swen JJ, Cats A, Mathijssen RHJ, Jacobs BAW.   +12 more
europepmc   +1 more source

Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial. [PDF]

Signal Transduct Target Ther
Wu W, Yang Y, Chen H, Lu Y, Zeng Y, Zhao J, Du C, Lin Y, Peng P, Huang M, Zhang Y, Ouyang Q, Ding L, Cheng Z, Wen Y, Wu Z, Ye J, Ling L, Wang K, Lu Y, Zou G, Zhong J, Wang H, Lin D, Zeng, Yao C, Chen Q, Zou L, Wang S, Yu Y, Yuan Z, Wang Y, Yao H.   +32 more
europepmc   +1 more source

Alternate-day Capecitabine Plus Trastuzumab for Frail HER2-positive Gastric Cancer: A Pilot Case Series. [PDF]

In Vivo
Odaira N, Sasaki M, Kanda J, Muneoka K.
europepmc   +1 more source

Management of HER2+ Breast Cancer with and without Brain Metastases in Saudi Arabia: Literature Insights and an Expert Survey of Current Practices. [PDF]

Breast Cancer (Dove Med Press)
Kullab S, Refae A, Altwairgi A, Abusanad A, Elsamany S, Abdelhafiez NA, Basulaiman B, Zahralliyali A, Alshangiti AA, Al-Mubarak M, Alwbari A, Alharbi A, Osman A, Kiwan H, Alaklabi S.   +14 more
europepmc   +1 more source

Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study. [PDF]

Breast Cancer (Dove Med Press)
Birsin Z, Güren AK, Aliyev V, Guliyev M, Jeral S, Cebeci S, Çerme E, Günaltılı M, Abbasov H, Çiçek E, Atak S, Sarı M, Demirci NS, Alan Ö.   +13 more
europepmc   +1 more source

Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era. [PDF]

Front Surg
Bartsch F, Scholz C, Gröger LK, Bachmann L, Baumgart J, Lederer AK, Mittler J, Hoppe-Lotichius M, Straub BK, Foerster F, Weinmann A, Tagkalos E, Lang H.   +12 more
europepmc   +1 more source

Real-World Efficacy of Metronomic Chemotherapy in Advanced Breast Cancer Across Molecular Subtypes. [PDF]

Cancer Med
Zhou H, Chen L, Lu Q, Wu H, Jiang K, Xu F, Wang S.   +6 more
europepmc   +1 more source

Adjuvant chemotherapy in elderly colon cancer patients: when less may be more. [PDF]

J Gastrointest Oncol
Eslinger C, Sonbol MB.
europepmc   +1 more source

Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy. [PDF]

Breast Cancer Res Treat
Tavares GM, Ramalho SOB, da Silva LR, Telles GD, de Paiva Silva GR, Torresan RZ, Derchain SFM.   +6 more
europepmc   +1 more source

Severe Hyperammonemic Encephalopathy Associated With Gastrointestinal Bleeding During Capecitabine and Oxaliplatin Chemotherapy in a Patient With Rectal Adenocarcinoma. [PDF]

Cureus
Komatsu T, Agrawal VA.
europepmc   +1 more source